CeriBell, Inc (CBLL) - Total Assets
Based on the latest financial reports, CeriBell, Inc (CBLL) holds total assets worth $178.08 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See CeriBell, Inc balance sheet quality to measure how much of total assets are equity-financed.
CeriBell, Inc - Total Assets Trend (2022–2025)
This chart illustrates how CeriBell, Inc's total assets have evolved over time, based on quarterly financial data. Check how tangible is CeriBell, Inc's equity to evaluate the tangible quality of the company's equity base.
CeriBell, Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
CeriBell, Inc's total assets of $178.08 Million consist of 95.4% current assets and 4.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 20.7% |
| Accounts Receivable | $15.05 Million | 7.7% |
| Inventory | $7.29 Million | 3.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $805.00K | 0.4% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2022–2025)
This chart illustrates how CeriBell, Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see CBLL stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CeriBell, Inc's current assets represent 95.4% of total assets in 2025, an increase from 92.3% in 2022.
- Cash Position: Cash and equivalents constituted 20.7% of total assets in 2025, down from 78.9% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2022.
- Asset Diversification: The largest asset category is accounts receivable at 7.7% of total assets.
CeriBell, Inc Competitors by Total Assets
Key competitors of CeriBell, Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.62 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
CeriBell, Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 10.30 | 17.36 | 2.41 |
| Quick Ratio | 9.87 | 16.81 | 2.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $150.50 Million | $193.59 Million | $30.36 Million |
CeriBell, Inc - Advanced Valuation Insights
This section examines the relationship between CeriBell, Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.98 |
| Latest Market Cap to Assets Ratio | 3.35 |
| Asset Growth Rate (YoY) | -13.1% |
| Total Assets | $195.80 Million |
| Market Capitalization | $655.65 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values CeriBell, Inc's assets at a significant premium (3.35x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: CeriBell, Inc's assets decreased by 13.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for CeriBell, Inc (2022–2025)
The table below shows the annual total assets of CeriBell, Inc from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $195.80 Million | -13.14% |
| 2024-12-31 | $225.41 Million | +282.56% |
| 2023-12-31 | $58.92 Million | -31.85% |
| 2022-12-31 | $86.46 Million | -- |
About CeriBell, Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly t… Read more